Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

被引:170
作者
Zhang, Y
Louboutin, JP
Zhu, J
Rivera, AJ
Emerson, SG
机构
[1] Univ Penn, Sch Med, Div Hematol & Oncol, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
关键词
D O I
10.1172/JCI200214989
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To understand the relationship between host antigen-presenting cells (APCs) and donor T cells in initiating graft-versus-host disease (GVHD), we followed the fate of host dendritic cells (DCs) in irradiated CS7BL/6 (136) recipient mice and the interaction of these cells with minor histocompatibility antigen- (miHA-) mismatched CD8(+)T cells from C3H.SW donors. Host CD11c(+) DCs were rapidly activated and aggregated in the T cell areas of the spleen within 6 hours of lethal irradiation. By 5 days after irradiation, <1% of host DCs were detectable, but the activated donor CD8(+) T cells had already undergone as many as seven divisions. Thus, proliferation of donor CD8(+) T cells preceded the disappearance of host DCs. When C3H.SW donor CD8(+)T cells were primed in vivo in irradiated B6 mice or ex vivo by host CD11c(+) DCs for 24-36 hours, they were able to proliferate and differentiate into IFN-gamma-producing cells in beta(2)-microglobulin-deficient (beta(2)m(-/-)) B6 recipients and to mediate acute GVHD in beta(2)m(-/-) --> B6 chimeric mice. These results indicate that, although host DCs disappear rapidly after allogeneic bone marrow transplantation, they prime donor T cells before their disappearance and play a critical role in triggering donor CD8(+)T cell-mediated GVHD.
引用
收藏
页码:1335 / 1344
页数:10
相关论文
共 45 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions [J].
Blazar, BR ;
Lees, CJ ;
Martin, PJ ;
Noelle, RJ ;
Kwon, B ;
Murphy, W ;
Taylor, PA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4901-4909
[3]   Recent advances in graft-versus-host disease (GVHD) prevention [J].
Blazar, BR ;
Korngold, R ;
Vallera, DA .
IMMUNOLOGICAL REVIEWS, 1997, 157 :79-109
[4]   The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism [J].
den Haan, JMM ;
Meadows, LM ;
Wang, W ;
Pool, J ;
Blokland, E ;
Bishop, TL ;
Reinhardus, C ;
Shabanowitz, J ;
Offringa, R ;
Hunt, DF ;
Engelhard, VH ;
Goulmy, E .
SCIENCE, 1998, 279 (5353) :1054-1057
[5]   CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo [J].
den Haan, JMM ;
Lehar, SM ;
Bevan, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1685-1695
[6]   IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN [J].
DENHAAN, JMM ;
SHERMAN, NE ;
BLOKLAND, E ;
HUCZKO, E ;
KONING, F ;
DRIJFHOUT, JW ;
SKIPPER, J ;
SHABANOWITZ, J ;
HUNT, DF ;
ENGELHARD, VH ;
GOULMY, E .
SCIENCE, 1995, 268 (5216) :1476-1480
[7]   Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates [J].
Ferlazzo, G ;
Semino, C ;
Spaggiari, GM ;
Meta, M ;
Mingari, MC ;
Melioli, G .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (12) :1741-1747
[8]  
Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X
[9]  
Ferrara JLM, 1998, BONE MARROW TRANSPL, V21, pS13
[10]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667